CYTOSORBENTS CORPORATION (CTSO) Net margin 2016–2025
CYTOSORBENTS CORPORATION (CTSO) net profit margin by fiscal year — reported net income divided by reported revenue.
-22.1%FY2025 · since FY2016: -123.5% → -22.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -22.1% | +36.1 pp |
| FY2024 | -58.2% | +35.9 pp |
| FY2023 | -94.1% | +0.5 pp |
| FY2022 | -94.6% | -37.7 pp |
| FY2021 | -56.9% | -37.8 pp |
| FY2020 | -19.1% | +58.1 pp |
| FY2019 | -77.2% | -0.7 pp |
| FY2018 | -76.5% | -20.6 pp |
| FY2017 | -55.8% | +67.6 pp |
| FY2016 | -123.5% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice